Date published: 2025-9-8

021-6093-6350

SCBT Portrait Logo
Seach Input

C3aR 抗体 (17): sc-53782

3.0(1)
寫評論提問

说明书
  • C3aR抗体(17)是小鼠单克隆IgG2b κ, 在4篇文献中引用,规格为200 µg/ml
  • 免疫human物种的C3aR
  • 推荐用于 human 来源的C3aR WB, IP, IF 和 FCM检测
  • 还可偶联藻红蛋白 以及 FITC 用于IF, IHC(P) 和 FCM
  • m-IgG Fc BP-HRP2b BP-HRP">m-IgG2b BP-HRPm-IgGκ BP-HRP是C3aR Antibody (17) 适用于 WB 应用。 的首选辅助检测试剂。这些试剂现与C3aR Antibody (17) 打包提供(请参阅下面的订购信息)。

快捷链接

関連項目

补体C3前体包含补体C3β链、补体C3α链、C3a过敏毒素、补体C3bα链、补体C3c片段、补体C3dg片段、补体C3g片段、补体C3d片段和补体C3f片段。C3a、C4a和C5a是补体激活过程中释放的强效过敏毒素。补体激活是造血谱系细胞特有的配体-表面蛋白相互作用系统,有助于消除病原体。C3a和C5a的分泌与哮喘和细菌性脑膜炎等病理生理表现相关。这些蛋白质与各自存在于髓系白细胞表面的G蛋白偶联受体(C3aR、C5aR)结合,会诱导促炎反应,如细胞脱粒、平滑肌收缩、花生四烯酸代谢、细胞因子释放、白细胞活化和细胞趋化性。C3aR在大脑和活化的B淋巴细胞中表达,而C5aR则普遍存在于肝细胞、肺细胞、平滑肌细胞和内皮细胞的表面。激活后,C3aR和C5aR容易发生由GRK介导的快速磷酸化和网格蛋白包被囊泡靶向作用。C5aR利用Ras-Raf-ERK1/2级联反应并与Gi/G16蛋白偶联。

仅限研究使用。不适用于诊断和治疗用途。

Alexa Fluor® 是Molecular Probes Inc., OR., USA的商标

LI-COR®和 Odyssey® 是LI-COR Biosciences的注册商标

C3aR 抗体 (17) 参考文献:

  1. 补体C3aR失活可减轻Tau病理,逆转Tau病模型和阿尔茨海默病中免疫网络失调。  |  Litvinchuk, A., et al. 2018. Neuron. 100: 1337-1353.e5. PMID: 30415998
  2. 低灌注后,小胶质细胞通过补体C3/C3aR途径加剧白质损伤。  |  Zhang, LY., et al. 2020. Theranostics. 10: 74-90. PMID: 31903107
  3. 补体C3-C3aR通路介导癫痫持续状态后小胶质细胞-星形胶质细胞的相互作用。  |  Wei, Y., et al. 2021. Glia. 69: 1155-1169. PMID: 33314324
  4. C3aR在调节细菌感染的抵抗力方面起着双重作用。  |  Corcoran, JA. and Napier, BA. 2022. PLoS Pathog. 18: e1010657. PMID: 35925892
  5. 幽门螺杆菌外膜囊泡通过C3-C3aR信号传导促进阿尔茨海默病的发病。  |  Xie, J., et al. 2023. J Extracell Vesicles. 12: e12306. PMID: 36792546
  6. Cntnap4部分缺失通过星形胶质细胞-小胶质细胞C3-C3aR途径加剧α-突触核蛋白病理。  |  Zhang, W., et al. 2023. Cell Death Dis. 14: 285. PMID: 37087484
  7. 补体C3aR的耗竭逆转了HIF-1α诱导的代谢障碍,并增强了小胶质细胞对Aβ病理的反应。  |  Gedam, M., et al. 2023. J Clin Invest. 133: PMID: 37317973
  8. C3a/C3aR与TGF-β协同作用,通过激活NLRP3炎症小体促进肾小管上皮细胞的上皮-间质转化。  |  You, D., et al. 2023. J Transl Med. 21: 904. PMID: 38082306
  9. C3aR启动的信号传导是膜性肾病中足细胞损伤的关键机制。  |  Zhang, Q., et al. 2024. JCI Insight. 9: PMID: 38227377
  10. 肿瘤相关巨噬细胞中的NFAT1-C3a-C3aR正反馈回路促进胶质瘤干细胞的恶性表型。  |  Zhang, Y., et al. 2024. Cancer Immunol Res. 12: 363-376. PMID: 38289255

订购信息

产品名称产品编号规格价格数量收藏夹

C3aR 抗体 (17)

sc-53782
200 µg/ml
RMB2377.00

C3aR (17): m-IgG Fc BP-HRP 套装

sc-536999
200 µg Ab; 10 µg BP
RMB2662.00

C3aR (17): m-IgGκ BP-HRP 套装

sc-534179
200 µg Ab; 40 µg BP
RMB2662.00

C3aR (17): m-IgG2b BP-HRP 套装

sc-549847
200 µg Ab; 10 µg BP
RMB2662.00

C3aR 抗体 (17) FITC

sc-53782 FITC
200 µg/ml
RMB2482.00

C3aR 抗体 (17) PE

sc-53782 PE
200 µg/ml
RMB2580.00

How can C3aR (17): sc-53782 mouse monoclonal antibody be used for double or triple staining, if the other primary antibodies are also raised in mouse?

Asked by: Professor Griffin
In this case, we recommend using a directly conjugated mouse monoclonal primary antibody. This antibody is available conjugated to phycoerythrin (sc-53782 PE) or fluoroscein (sc-53782 FITC).
Answered by: Technical Support
Date published: 2019-05-29
  • y_2025, m_9, d_7, h_4CST
  • bvseo_bulk, prod_bvqa, vn_bulk_3.0.42
  • cp_1, bvpage1
  • co_hasquestionsanswers, tq_1
  • loc_zh_CN, sid_53782, prod, sort_[SortEntry(order=LAST_APPROVED_ANSWER_SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getContent, 104ms
  • QUESTIONS, PRODUCT
Rated 3 out of 5 by from WB: Strong staining obtained using humanWB: Strong staining obtained using human transfected lysates. -SCBT QC
Date published: 2014-04-03
  • y_2025, m_9, d_7, h_4
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.42
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_zh_CN, sid_53782, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getReviews, 19ms
  • REVIEWS, PRODUCT
C3aR 抗体 (17) is rated 3.0 out of 5 by 1.
  • y_2025, m_9, d_7, h_4
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.42
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_zh_CN, sid_53782, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getAggregateRating, 110ms
  • REVIEWS, PRODUCT